Market Research Report
Drug Eluting Stent Market in China - Industry Research Report 2015-2019
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||341722|
|Published||Content info||56 Pages
|Drug Eluting Stent Market in China - Industry Research Report 2015-2019|
|Published: October 7, 2015||Content info: 56 Pages||
Drug eluting stent, also known as medicated coronary stent, is a tiny, expandable metal mesh tube that is covered with a pharmacologic agent. It prevents artery blockages in patients after angioplasty. It also eliminates the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels).
Technavio's analysts forecast the drug eluting stent market in China to grow at a CAGR of 10.70% over the period 2014-2019.
This report covers the present and future scenario of the drug eluting stent market in China for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of drug eluting stents.
Technavio's report, Drug Eluting Stent Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the drug eluting stent market in China and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.